Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Mailed nicotine replacement therapy (NRT)
The University of Hong Kong
Smoking Cessation
1 trial -
Maternal Nutritional Supplement
Abbott Australasia Pty Ltd
Breast Feeding
1 trial -
Medical Treatment
The First People's Hospital of Lianyungang
Basilar Artery Occlusion
1 trial -
Medolac human milk based human milk fortifier (MHMHMF)
NORTHWEST BIOTHERAPEUTICS INC
Infant, Premature, Diseases
1 trial -
Melatonin supplement intervention
United Therapeutics Europe Ltd
Physical Exercise
1 trial -
Mesalazine
Chinese University of Hong Kong
Colitis, Ulcerative
1 trial -
Metformin pretreatment before ovarian stimulation
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Metformin
1 trial -
Midazolam 0.03mg/kg
Hospital Authority, Hong Kong
Child
1 trial -
Midazolam premedication
Hospital Authority, Hong Kong
Midazolam Premedication
1 trial -
Mindfulness meditation based on brain-computer interface
The First People's Hospital of Lianyungang
Atrial Fibrillation
1 trial -
Mitoquinone mesylate (MitoQ)
United Therapeutics Europe Ltd
Cold Exposure
1 trial -
Mitoxantrone hydrochloride liposome injection
The First People's Hospital of Lianyungang
Diffuse Large B-cell Lymphoma
1 trial -
Multiple-dose of Ciprofloxacin prophylaxis
The First People's Hospital of Lianyungang
Kidney Stones
1 trial -
Mupirocin
Hospital Authority, Hong Kong
Peritoneal Dialysis-related Infection
1 trial -
N-butyl-2-cyanoacrylate
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Gastric Varices
1 trial -
Naglazyme®
BioMarin Pharmaceutical Australia Pty Ltd
Maroteaux-Lamy Syndrome
1 trial -
New infant formula
United Therapeutics Europe Ltd
Functional Gastrointestinal Disorders
1 trial -
Nicotine Replacement
BRIGHT MINDS BIOSCIENCES INC.
Cigarette Smoking-Related Carcinoma
2 trials -
Nicotine Replacement Therapy (Habitrol)
BRIGHT MINDS BIOSCIENCES INC.
Nicotine Dependence
1 trial -
Nicotine Replacement Treatment (NRT)
BRIGHT MINDS BIOSCIENCES INC.
Substance Abuse
1 trial -
Nicotine Replacement therapy
The University of Hong Kong
Smoking
1 trial -
Nicotine replacement therapy sampling
United Therapeutics Europe Ltd
Smoking Cessation
1 trial -
Normal Saline (Placebo)
The First People's Hospital of Lianyungang
Disease of Respiratory System
1 trial -
Obinutuzumab
The First People's Hospital of Lianyungang
Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources